Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

Nature Genetics

Volumn 8, Issue 2, 1994, Pages 171-176

  Meir, Erwin G Van ^a,b   Polverini, Peter J ^c   Chazin, Victoria R ^a   Su Huang, H J ^a   De Tribolet, Nicolas ^b   Cavenee, Webster K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; INHIBITOR PROTEIN;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CELL SECRETION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BRAIN NEOPLASMS; CELL MOVEMENT; CORNEA; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BIOSYNTHESIS; PROTEINS; RATS; RATS, INBRED F344; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0028129836     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1094-171     Document Type: Article

References (36)

1. Folkman, J. & Klagsbrun, M. Angiogenic factors. Science 235, 442-447 (1987).
2. Folkman, J., Long, D.M. & Becker, F.F. Growth and metastasis of tumor in organ culture. Cancer 16, 453 (1963).
3. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
4. Brem, S., Cotran, R. & Folkman, J. Tumor angiogenesis: a quantitative method for histologic grading. J. natn. Cancer Inst. 48, 347-356 (1972).
5. Russell, D.C. & Rubinstein, L J. Pathology of tumours of the nervous system. (Edward Arnold, London, 1989).
6. Cavenee, W.K., Scrable, H.J. & James, C.D. Molecular genetics of human cancer predisposition and progression. Mutat. Res. 247, 199-202 (1991).
7. Nigro, J.M. et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 342, 705-708 (1989).
8. Sidransky, D. et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355, 846-847 (1992).
9. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49-53 (1991).
10. Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumour suppressor gene.Nature 351, 453-456 (1991).
11. Lane, D.P. P53, guardian of the genome. Nature 358, 15-16 (1992).
12. Kern, S.E. et al. Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711 (1991).
13. Ginsberg, D., Mechta, F., Yaniv, M. & Oren, M. Wild-type p53 can down-modulate the activity of various promoters. Proc. natn. Acad. Sci. U.S.A.88, 9979-9983 (1991).
14. Farmer, G. et al. Wild-type p53 activates transcription in vitro. Nature 358, 83-86 (1992).
15. Cho, Y., Gorina, S., Jeffrey, P.D. & Pavletich, N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355 (1994).
16. Baker, S.J., Markowitz, S., Fearon, E.R., Wilson, J.K. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53.Science 249, 912-915 (1990).
17. Martinez, J., Georgoff, I., Martinez, J. & Levine, A.J. Cellular localization and cell cycle regulation by a temperate-sensitive p53 protein. Genes Dev. 5, 151-159 (1991).
18. Diller, L. et al. p53 functions as a cell cycle control protein in osteosarcomas. Molec. cell. Biol. 10, 5772-5781 (1990).
19. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DNA damage.Cancer Res. 51, 6304-6311 (1991).
20. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. & Wahl, G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948 (1992).
21. Livingstone, L.R. et al. Altered cell cycle arrest and gene amplicication potential accompany loss of wild-type p53. Cell 70, 923-935 (1992).
22. Kemp, C.J., Donehower, L.A., Bradley, A. & Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822 (1993).
23. Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcoma and other neoplasms. Science 250, 1233-1238 (1990).
24. Srivastava, S., Zou, Z.Q., Pirollo, K., Blattner, W. & Chang, E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni Syndrome. Nature 348, 747-749 (1990).
25. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. natn. Acad. Sci. U.S.A. 89, 5547-5551 (1992).
26. Van Meir, E.G. et al. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54, 649-652 (1994).
27. EI-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
28. Glaser, B.M., D'Amore, P.A., Seppa, H. & Schiffmann, E. Adult tissues contain chemottractants for vascular endothelial cells. Nature 288, 483-484 (1980).
29. Rastinejad, F., Polverini, P.J. & Bouck, N.P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345-355 (1989).
30. Gall, C.M. in Astrocytomas: diagnosis, treatment, and biology (eds Black, P.M., Schoene, W.C. & Lampson, L.A.) 241-249 (Blackwell Scientific Publications, Boston, 1991).
31. Klagsbrun, M. & D'Amore, P.A. Regulators of angiogenesis. A. Rev. Physiol. 53, 217-239 (1991).
32. Plate, K.H., Breier, G., Weich, H.A. & Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848 (1992).
33. Shweiki, D., Itin, A., Softer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.Nature 359, 843-845 (1992).
34. Kim, K.J. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844 (1993).
35. Kern, S.E. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-830 (1992).
36. Good, D.J. et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. natn. Acad. Sci. U.S.A. 87, 6624-6628 (1990).